{"database": "lobbying", "table": "lobbying_activities", "rows": [[2470520, "ed995da5-1e49-430b-8de7-d15e1397135d", "Q2", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "NATIONAL ASSOCIATION OF BOARDS OF PHARMACY", 2020, "second_quarter", "PHA", "Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response", "Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 110000, null, 0, 0, "2020-07-17T09:25:12.707000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2470520"], "units": {}, "query_ms": 0.31457399018108845, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}